Form 4: Atlassian Co-CEO Michael Cannon-Brookes Executes Stock Sales Under 10b5-1 Trading Plan

Atlassian's Co-CEO, Michael Cannon-Brookes, sold shares of Class A Common Stock on August 1, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Michael Cannon-Brookes, Co-CEO and Co-Founder of Atlassian, executed multiple sales of Class A Common Stock on August 1, 2024.
• The sales were conducted under a Rule 10b5-1 trading plan adopted on February 8, 2024.
• The transactions involved the disposal of shares held directly and indirectly through a trust (CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust).
• The prices per share varied across the transactions, ranging from approximately $170.05 to $178.80.
• A total of 8,448 shares were sold across eight transactions.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to stock sales under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.

Risks

• Executive stock sales can sometimes be perceived negatively by investors, potentially impacting stock price, although sales under a 10b5-1 plan are generally viewed as less concerning.

Future Outlook

The reporting person will likely continue to execute sales under the 10b5-1 trading plan.

Industry Context

Insider sales are a common occurrence in publicly traded companies. The use of a 10b5-1 trading plan allows insiders to sell shares without being accused of trading on non-public information.

Comparison to Industry Standards

• Sales by executives under 10b5-1 plans are a common practice among publicly traded companies, including Atlassian's peers like Adobe (ADBE), Salesforce (CRM), and ServiceNow (NOW).
• These plans are designed to allow insiders to diversify their holdings and manage personal finances without raising concerns about insider trading.
• The volume and frequency of sales can vary widely depending on the individual's financial situation and the terms of the plan.

Stakeholder Impact

• The stock sales could have a minor impact on shareholders if they perceive the sales negatively, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates